|
|
|
|
AP-1 |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
AP-1 Inhibitors |
1989 |
c-JUN peptide |
JNK/c-Jun interaction
inhibitor |
5309 |
SP 100030 |
NF-κB and AP-1 dual
inhibitor |
2476 |
SR 11302 |
AP-1 inhibitor;
antitumor agent |
7317 |
T 5224 |
Selective inhibitor
of c-Fos/activator protein (AP)-1 |
|
|
|
|
Aryl
Hydrocarbon Receptor |
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
Aryl Hydrocarbon Receptor Agonists |
6321 |
10-Cl-BBQ |
Potent
aryl hydrocarbon receptor (AhR) agonist; orally bioavailable |
5304 |
FICZ |
High
affinity aryl hydrocarbon receptor (AhR) agonist |
1803 |
ITE |
Endogenous
agonist for the transcription factor aryl hydrocarbon receptor |
3873 |
MeBIO |
AhR
agonist. Inactive analog of BIO (Cat. No. 3194) |
1267 |
Pifithrin-α
hydrobromide |
Aryl
hydrocarbon receptor agonist. Also p53 inhibitor |
Aryl Hydrocarbon Receptor Antagonists |
3858 |
CH 223191 |
Potent
aryl hydrocarbon receptor (AhR) antagonist |
7086 |
StemRegenin 1 |
Aryl
hydrocarbon receptor (AhR) antagonist; promotes HSC expansion and engraftment |
Ligands |
4393 |
L-Kynurenine |
Tryptophan
catabolite; endogenous aryl hydrocarbon receptor ligand |
Other |
4995 |
Phortress |
Prodrug
of the antitumor agent 5F 203 |
|
|
|
|
Hypoxia
Inducible Factor |
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
Hypoxia Inducible Factor (HIF)
Inhibitors |
5953 |
Adaptaquin |
HIF-prolyl
hydroxylase-2 (PHD2) inhibitor; antioxidant |
5582 |
TAT-cyclo-CLLFVY |
Selective
HIF-1 dimerization inhibitor |
4408 |
DMOG |
Inhibitor
of hypoxia-inducible factor α (HIF-α) prolyl hydroxylase (HIF-PH) |
5520 |
Echinomycin |
Highly
potent and selective HIF-1α inhibitor |
6653 |
FM19G11 |
HIF
α-subunit inhibitor |
5655 |
GN 44028 |
Potent
HIF-1α inhibitor |
4451 |
IOX 2 |
Potent,
selective HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
4324 |
KC7F2 |
HIF-1α
inhibitor; down-regulates HIF-1α protein synthesis |
6322 |
LW 6 |
HIF-1α
inhibitor; inhibits cellular accumulation of HIF-1α; also malate
dehydrogenase-2 inhibitor |
2954 |
PX 12 |
Thioredoxin-1
inhibitor; attenuates expression of HIF-1α |
5243 |
TC-S 7009 |
High
affinity and selective HIF-2α inhibitor |
6156 |
VH 298 |
High-affinity
inhibitor of VHL; blocks interaction of VHL and HIF-α |
Hypoxia Inducible Factor (HIF) Activators |
4565 |
ML 228 |
HIF
pathway activator |
Other |
4705 |
Chetomin |
Blocks
interaction of HIF-1α, HIF-2α and STAT2 with CBP/p300 |
6157 |
cis VH 298 |
Negative
control for VH 298 |
5764 |
Deferoxamine mesylate |
Hypoxia
mimetic; also iron chelator |
7287 |
FAM-DEALA-Hyp-YIPD |
Fluorescent
HIF-1α peptide |
7452 |
FAM-DEALAHypYIPMDDDFQLRSF |
Fluorescent
HIF-1α peptide |
|
|
|
|
MYC |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
MYC Inhibitors |
4406 |
10058-F4 |
Inhibits c-Myc-Max
dimerization |
5306 |
KJ Pyr 9 |
High affinity Myc
inhibitor |
|
|
|
|
NF-κB
and IκB |
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
NF-κB and IκB Inhibitors |
4547 |
ACHP |
Selective
IKKα and IKKβ inhibitor; blocks NF-κB-DNA binding |
4857 |
Amlexanox |
Inhibitor
of TBK1 and IKKε; antiallergic agent |
1777 |
Arctigenin |
Inhibitor
of IκBα phosphorylation. Also inhibits MEK1 |
1743 |
Bay 11-7085 |
Irreversible
inhibitor of TNF-α-induced IκBα phosphorylation |
1744 |
Bay 11-7821 |
Indirect
inhibitor of IκBα phosphorylation |
5273 |
Bengamide B |
Potent
inhibitor of NF-κB activation |
5300 |
BI 605906 |
Selective
IKKβ inhibitor |
4806 |
BMS 345541 |
Selective
allosteric inhibitor of IKK; anti-inflammatory |
5821 |
C-DIM 12 |
Inhibits
NF-κB-dependent gene expression; Nurr1 activator |
2743 |
Caffeic acid
phenethyl ester |
Specific
inhibitor of NF-κB activation |
2509 |
Cardamonin |
Inhibitor
of NF-κB activation; anti-inflammatory |
6646 |
CDDO-Me |
NF-κB
pathway inhibitor; inhibits IKKβ; also Nrf2 pathway activator |
3203 |
Celastrol |
Inhibits
TNF-α-induced NF-κB activation |
6237 |
FPS ZM1 |
High
affinity antagonist of the receptor for advanced glycation end products
(RAGE) |
2637 |
Gliotoxin |
Immunosuppressant;
inhibits NF-κB and cytokine production |
5672 |
GSK 319347A |
Potent
and selective IKKε inhibitor |
4590 |
Honokiol |
Blocks
NF-κB activation; also anti-inflammatory and antioxidant |
2539 |
IKK 16 |
Selective
inhibitor of IKK |
2611 |
IMD 0354 |
Inhibitor
of IKKβ |
5699 |
IP7e |
Blocks
NF-κB pathway; also potent Nurr1 activator |
5846 |
IT 901 |
NF-κB
c-Rel subunit inhibitor |
2874 |
Luteolin |
Blocks
NF-κB activation |
1748 |
MG 132 |
Inhibits
NF-κB activation; proteasome and calpain inhibitor |
4899 |
ML 120B
dihydrochloride |
Novel
IKK2-selective inhibitor |
4354 |
ML 130 |
Inhibits
NOD1-induced NF-κB activation |
0610 |
Parthenolide |
NF-κB
inhibitor; also 5-HT release inhibitor |
4238 |
PF 184 |
Potent
and selective IKKβ inhibitor |
1554 |
Piceatannol |
Inhibits
TNF-induced NF-κB activation |
1947 |
PR 39 (porcine) |
IκBα
inhibitor |
3731 |
Pristimerin |
Suppresses
NF-κB activation |
4569 |
PS 1145
dihydrochloride |
Selective
IKK inhibitor; orally active |
0727 |
Pyrrolidinedithiocarbamate
ammonium |
Inhibits
NF-κB, prevents increase in NOS mRNA |
6259 |
RAGE antagonist
peptide |
Receptor
for advanced glycation end products (RAGE) antagonist |
3318 |
SC 514 |
IKKβ
inhibitor; attenuates NF-κB-induced gene expression |
6829 |
(R)-Shikonin |
Blocks
TNF-α and NF-κB signaling; induces necroptosis; anti-inflammatory |
5309 |
SP 100030 |
NF-κB
and AP-1 dual inhibitor |
4935 |
Sulfasalazine |
Inhibitor
of NF-κB activation; also inhibits SXC and folate transporter 1 |
4426 |
Tanshinone IIA |
Inhibits
NF-κB and AP-1 DNA binding. Displays antioxidant properties |
2559 |
TPCA-1 |
Potent,
selective inhibitor of IKKβ |
2816 |
Withaferin A |
Inhibits
NF-κB activation |
6111 |
Zoledronic Acid |
NF-κB
signaling inhibitor; also potent farnesyl diphosphate (FPP) synthase
inhibitor |
NF-κB and IκB Activators |
3906 |
Betulinic acid |
Activates
NF-κB; antitumor and anti-HIV agent. Also TGR5 agonist |
6124 |
(R)-2-Hydroxyglutaric
acid disodium salt |
NF-κB
activator; also KDM4A inhibitor |
5739 |
Prostratin |
NF-κB
activator; also PKC activator |
Other |
1126 |
Dexamethasone |
Reduces
levels of activated NF-κB in immature dendritic cells; anti-inflammatory
glucocorticoid |
|
|
|
|
NFAT |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
NFAT Inhibitors |
3930 |
NFAT Inhibitor |
Inhibitor
of calcineurin-mediated NFAT activation |
5710 |
NFAT inhibitor, Cell
Permeable |
Cell
permeable NFAT inhibitor |
Other |
4210 |
Ascomycin |
Calcineurin
phosphatase inhibitor; analog of FK 506 (Cat. No. 3631) |
1101 |
Cyclosporin A |
Calcineurin
inhibitor |
3631 |
FK 506 |
Potent
calcineurin inhibitor; immunosuppressant |
2162 |
INCA-6 |
Inhibitor
of calcineurin-NFAT association |
|
|
|
|
Nrf2 |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
Nrf2 Inhibitors |
6243 |
ML 385 |
Nrf2
inhibitor; phenotypically lethal |
Nrf2 Activators |
5145 |
AI-3 |
ARE
activator; induces Nrf2-ARE-dependent transcription |
4737 |
CDDO Im |
Nrf2
signaling activator |
6646 |
CDDO-Me |
Nrf2
pathway activator; also NF-κB pathway inhibitor; inhibits IKKβ |
4512 |
DMF |
Activator
of Nrf2 pathway; neuroprotective |
7199 |
(±)-Eriodictyol |
Activates
Nrf2/ARE signaling; antioxidant; also potent TRPV1 antagonist |
6172 |
INF 4E |
Activates
Keap1-Nrf2 pathway; also caspase-1 and NLRP3 inflammasome inhibitor |
5625 |
ML 334 |
Inhibitor
of Keap1- Nrf2 interaction |
4511 |
MMF |
Activator
of Nrf2 pathway; primary metabolite of DMF (Cat. No. 4512) |
5293 |
NK 252 |
Nrf2
activator |
6662 |
4-Octyl itaconate |
Nrf2
activator; cell permeable |
5294 |
Oltipraz |
Nrf2
activator |
5707 |
RA 839 |
Nrf2
activator; inhibits Nrf2/Keap1 interaction |
4811 |
TAT 14 |
Nrf2
pathway activator; blocks Nrf2/Keap1 interaction |
|
|
|
|
p53 |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
p53 Inhibitors |
1267 |
Pifithrin-α
hydrobromide |
p53
inhibitor. Also aryl hydrocarbon receptor agonist |
3843 |
Cyclic Pifithrin-α
hydrobromide |
p53
inhibitor |
2653 |
Pifithrin-μ |
Inhibitor
of p53-mitochondrial binding |
p53 Activators |
3503 |
HLI 373 |
Hdm2
inhibitor; activates p53-dependent transcription |
6904 |
Idasanutlin |
Potent
MDM2 inhibitor; inhibits MDM2-p53 interaction |
6615 |
KCC 07 |
BAI1/p53
signaling activator; inhibits MBD2 (Methyl-CpG-binding domain protein 2) |
2185 |
NSC 146109
hydrochloride |
Cell-permeable,
genotype-selective antitumor agent; activates p53-dependent transcription |
5065 |
NSC 319726 |
Reactivator
of mutant p53 |
3984 |
Nutlin-3 |
MDM2
antagonist; inhibits MDM2-p53 interaction |
6075 |
Nutlin 3a |
MDM2
antagonist; active enantiomer of Nutlin-3 (Cat. No. 3984) |
2443 |
RITA |
p53-MDM2
interaction inhibitor; antitumor |
5332 |
SP 141 |
High
affinity MDM2 inhibitor |
3365 |
Tenovin-1 |
Activates
p53 transcriptional activity |
3356 |
WR 1065
dihydrochloride |
p53
activator. Also ROS scavenger |
Other |
5417 |
BMH 21 |
p53
pathway activator; also RNA polymerase 1 inhibitor |
3362 |
MIRA-1 |
Restores
mutant p53 activity; proapoptotic |
4326 |
PhiKan 083 |
p53
stabilizing agent |
4396 |
Piperlongumine |
Induces
apoptosis; increases p53 and ROS levels in cancer cells |
1862 |
PRIMA-1 |
Restores
mutant p53 activity; induces apoptosis |
3710 |
PRIMA-1MET |
Restores
mutant p53 activity |
3214 |
RETRA hydrochloride |
Antitumor
agent; suppresses mutant p53-bearing cancer cells |
4240 |
SCH 529074 |
Restores
mutant p53 activity |
|
|
|
|
SREBP |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
SREBP Inhibitors |
4444 |
Fatostatin A |
Cell
permeable inhibitor of SREBP activation |
3354 |
PF 429242
dihydrochloride |
Competitive
inhibitor of SREBP site 1 protease |
|
|
|
|
STAT |
|
|
|
|
|
|
|
|
Cat. No. |
Product Name |
Activity |
STAT Inhibitors |
1571 |
Cucurbitacin I |
Selective
inhibitor of STAT3/JAK2 signaling |
6218 |
Galiellalactone |
STAT3
inhibitor; active in vivo |
6110 |
HJC 0416
hydrochloride |
STAT3
inhibitor |
5522 |
Napabucasin |
STAT3
inhibitor; also blocks cancer stem cell self-renewal |
4079 |
Niclosamide |
STAT3
inhibitor; also inhibits mTORC1 signaling |
4655 |
NSC 74859 |
Selective
STAT3 inhibitor |
3918 |
Pyrimethamine |
STAT3
inhibitor; also potent inhibitor of multidrug and toxin extrusion (MATE)
transporters and DHFR inhibitor |
5138 |
RSVA 405 |
STAT3
inhibitor; also AMPK activator |
3035 |
SD 1008 |
JAK2/STAT3
signaling pathway inhibitor |
2798 |
Stattic |
Selective
STAT3 inhibitor |
STAT Activators |
3945 |
Colivelin |
STAT3
activator; also protects against β-amyloid neurotoxicity |
Other |
3495 |
Fludarabine |
Purine
analog; inhibits cytokine-induced STAT1 activation |
6994 |
HODHBt |
STAT5-SUMO
protein-protein interaction inhibitor |